Trial Profile
EEG Biomarkers of Response in Depression.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 May 2015
Price :
$35
*
At a glance
- Drugs Venlafaxine (Primary)
- Indications Depressive disorders
- Focus Biomarker; Therapeutic Use
- 08 Oct 2008 New trial record.